Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax

Liver Transplantation and Surgery

Volumn 4, Issue 5, 1998, Pages 416-423

  Jeffries, M A ^a   Kazanjian, S ^a   Wilson, M ^a   Punch, J ^a   Fontana, R J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HEMODYNAMICS; HUMAN; HYDROTHORAX; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031709271     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040506     Document Type: Article

References (25)

1. 1 Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966 ; 64: 341–351. MEDLINE
2. 2 Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997 ; 17: 227–232. MEDLINE
3. 3 Moroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin. Chest 1996 ; 109: 1093–1096. MEDLINE
4. 4 Mentes BB, Kayhan B, Gorgul A, Unal S. Hepatic hydrothorax in the absence of ascites. Dig Dis Sci 1997 ; 42: 781–788. MEDLINE
5. 5 Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: Diagnosis and management. Gastroenterology 1985 ; 88: 188–191. MEDLINE
6. 6 Falchuk KR, Jacoby I, Colucci WS, Rybak ME. Tetracycline‐induced pleural symphysis for recurrent hydrothorax complicating ascites: A new approach to treatment. Gastroenterology 1977 ; 72: 319–322. MEDLINE
7. 7 Leveen HH, Piccone VA, Hutto RB. Management of ascites with hydrothorax. Am J Surg 1984 ; 148: 210–213. MEDLINE
8. 8 Ickard RW, Sawyers JL. Persistent hepatic hydrothorax after peritoneojugular shunt. Arch Surg 1980 ; 115: 1125–1127. MEDLINE
9. 9 Runyon BA, Greenblatt M, Ming RHC. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986 ; 81: 566–567. MEDLINE
10. 10 Ochs A, Rossle M, Haag K, Hauenstein K, Deibert P, Siegerstetter V, et al. The transjugular intrahepatic portosystemic stent‐shunt procedure for refractory ascites. N Engl J Med 1995 ; 332: 1192–1197. MEDLINE
11. 11 Somberg K, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function. Hepatology 1995 ; 21: 709–716. MEDLINE
12. 12 Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia‐Villareal L, et al. Transjugular intrahepatic portal‐systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995 ; 21: 986–894. MEDLINE
13. 13 Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Foshager MC, Ferral H, Hunter DW. Refractory ascites: Midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997 ; 205: 173–180. MEDLINE
14. 14 Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994 ; 89: 1520–1522. MEDLINE
15. 15 Gordon FD, Anastopoulus HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997 ; 25: 1366–1369. MEDLINE
16. 16 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. 1 Nephron 1976 ; 16: 31–41. MEDLINE
17. 17 Pugh RNH, Murray‐Lion IM, Davison JL, Pietroni MC, Williams R. Transection of oesophagus for bleeding oesophageal varices. Br J Surg 1973 ; 60: 646–649. MEDLINE
18. 18 LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with wallstent endoprosthesis: Results with 100 patients. Radiology 1993 ; 187: 413–420. MEDLINE
19. 19 Elcherothe J, Vons C, Franco D. Role of surgical therapy in management of intractable ascites. World J Surg 1994 ; 18: 240–245. MEDLINE
20. 20 Wong F, Sniderman K, Liu P, Alldina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: Effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995 ; 122: 816–822. MEDLINE
21. 21 Wong F, Sniderman K, Liu P, Blendis L. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic stent shunt. Gastroenterology 1997 ; 112: 899–907. MEDLINE
22. 22 Freedman AM, Sanyal AJ, Tisnado J, Cole PE, Shiffman ML, Luketic VA, et al. Complications of transjugular intrahepatic portosystemic shunt: A comprehensive review. Radiographics 1993 ; 13: 1185–1210. MEDLINE
23. 23 Light RW. Pleural diseasesed 3 Baltimore, MD: Williams & Wilkins. 1995 ;.
24. 24 Gane E, Langley P, Williams R. Massive ascitic fluid loss and coagulation disturbances after liver transplantation. Gastroenterology 1995 ; 109: 1631–1638. MEDLINE
25. 25 Spiess SE, Matalon TA, Jensen DM, Rosenblate JH, Brunner MC, Ganger DR. Transjugular Intrahepatic portosystemic shunt in nonliver transplant candidates: Is it indicated? Am J Gastroenterol 1995 ; 90: 1238–1243. MEDLINE